ArQule, Inc. (ARQL): Stock Offering News

ARQL – Prices underwritten public offering of 11 mln shares of its common stock at a price to the public of $5.50 per share.


Key Facts Surrounding This News Item


  • ARQL had a POWR Rating of B (Buy) coming into today.
  • ARQL was 6.03% above its 10-Day Moving Average coming into today.
  • ARQL was 13.73% above its 20-Day Moving Average coming into today.
  • ARQL was 37.04% above its 50-Day Moving Average coming into today.
  • ARQL was 78.81% above its 100-Day Moving Average coming into today.
  • ARQL was 153.32% above its 200-Day Moving Average coming into today.
  • ARQL had returned +272.73% year-to-date leading up to today’s news, versus a +5.40% return from the benchmark S&P 500 during the same period.

More Info About ArQule, Inc. (ARQL)


ArQule, Inc., a clinical-stage biotechnology company, researches and develops therapeutics for the treatment of cancer and rare diseases. The company was founded in 1993 and is based in Burlington, Massachusetts. View our full ARQL ticker page with ratings, news, and more.

ARQL at a Glance

ARQL Current POWR Rating™
Overall POWR Rating™
ARQL Current Price $3.02 8.48%
More ARQL Ratings, Data, and News

ARQL Price Reaction

The day of this event (Jul. 11, 2018)
ARQL Closing Price$5.90 4.07%
ARQL Volume6,828,300
842.09% from avg
Leading up to this event
ARQL 1-mo return16.48%
After this event
ARQL 1-day return6.59%
ARQL 3-day return16.26%
ARQL 5-day return20.12%

ARQL Price Chart


The Top Stocks For 2019

More ArQule, Inc. (ARQL) News View All

Event/Date Symbol News Detail Start Price End Price Change POWR Rating
Loading, please wait...
View All ARQL News
Page generated in 0.9987 seconds.